N/A
Completed N=71
Bright Light: An Adjunct Treatment for Combat Posttraumatic Stress Disorder (PTSD)
Source: ClinicalTrials.gov NCT00701064 ↗Enrolled (actual)
71
Serious AEs
0.0%
Results posted
Apr 2015
Primary outcomePrimary: Clinical Assessed PTSD Scale (CAPS-2) — 20.10; 8.84 change in units on scale
Summary
The investigators are testing novel treatments for combat PTSD: bright light exposure and negation ion exposure.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Clinical Assessed PTSD Scale (CAPS-2) |
20.10; 8.84 | — |
| PRIMARY Clinical Global Impressions Scale (CGI) |
2.61; 3.16 | — |
| SECONDARY Posttraumatic Stress Disorder Checklist (PCL-M) |
11.03; 6.25 | — |
Eligibility Criteria
Inclusion Criteria
- Veteran of Operation Iraqi Freedom or Operation Enduring Freedom with Posttraumatic Stress Disorder
- receiving other treatment or stopped other treatment prior to study
Exclusion Criteria
- bipolar disorder
- psychosis
- alcohol/drug abuse
Data sourced from ClinicalTrials.gov (NCT00701064). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.